Switzerland vs Tajikistan: Life science patents granted, by technology
Switzerland
6 patents
in 2023
Tajikistan
4 patents
in 2012
Switzerland rank
42nd
Tajikistan rank
45th
Life science patents granted, by technology over time
- Switzerland
- Tajikistan
How they compare
Switzerland currently reports 6 patents against 4 patents in Tajikistan, a difference of 2 patents.
That makes Switzerland's figure about 1.5 times Tajikistan's.
Across all 11 years both countries report, Switzerland has been ahead every year.
Switzerland ranks 42nd and Tajikistan ranks 45th of 65 countries.
Switzerland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Switzerland | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 12 patents | 6.5 patents | 5.5 patents | Switzerland |
| 2000s | 15.75 patents | 5.38 patents | 10.38 patents | Switzerland |
| 2010s | 12 patents | 4 patents | 8 patents | Switzerland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher life science patents granted, by technology, Switzerland or Tajikistan?
- Switzerland, at 6 patents against 4 patents in Tajikistan as of 2023.
- What is the difference in life science patents granted, by technology between Switzerland and Tajikistan?
- 2 patents, with Switzerland ahead.
- How many years of comparable data are there for Switzerland and Tajikistan?
- 11 years are reported by both, from 1998 to 2012.
- How do Switzerland and Tajikistan rank globally for life science patents granted, by technology?
- Switzerland ranks 42nd and Tajikistan ranks 45th of 65 countries.
- Where does this data come from?
- World Intellectual Property Organization (WIPO) (2025) β processed by Our World in Data, published as Life science patents granted, by technology. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of pharmaceutical patents granted by the filing office in a given year. Pharmaceutical patents typically cover new drugs, biological treatments or vaccines.